Massachusetts General Hospital ACTG CRS — Boston, Massachusetts

Massachusetts General Hospital ACTG CRS is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital ACTG CRS has participated in 45 clinical trials.

Therapeutic areas: HIV Infections, Peripheral Nervous System Disease, Cytomegalovirus Retinitis.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital ACTG CRS?

Massachusetts General Hospital ACTG CRS has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital ACTG CRS conducted?

Massachusetts General Hospital ACTG CRS has 45 clinical trials on record. Their work covers HIV Infections, Peripheral Nervous System Disease, Cytomegalovirus Retinitis.

Is Massachusetts General Hospital ACTG CRS accredited by Crixeo Health?

Yes — Massachusetts General Hospital ACTG CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Massachusetts General Hospital ACTG CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.